Invesco Capital Management Quote - P3WI | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Home
Investing
ETFs
Germany
TG
Invesco Capital Management LLC (P3WI) Share Price

Invesco Capital Management LLC (P3WI)

42.34

0.00

(0.00%)

Closed April 25 3:00PM

Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

42.34

Bid

42.21

Ask

42.40

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

42.34

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	FU
4	0	0	0	0	0	0	0	FU
12	0	0	0	0	0	0	0	FU
26	0	0	0	0	0	0	0	FU
52	0	0	0	0	0	0	0	FU
156	0	0	0	0	0	0	0	FU
260	0	0	0	0	0	0	0	FU

P3WI - Frequently Asked Questions (FAQ)

What is the current Invesco Capital Management share price?

The current share price of Invesco Capital Management is 42.34 €

What is the 1 year trading range for Invesco Capital Management share price?

Invesco Capital Management has traded in the range of 0.00 € to 0.00 € during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WW6Ww International Inc	0.3468 € (169.88%)	144.1k
OYM1Odyssey Marine Exploration Inc	1.39 € (82.89%)	120.38k
VW5Cannabist Company Holdings Inc	0.0643 € (78.61%)	153.41k
Z620Trillion Energy International Inc	0.0307 € (48.31%)	103.45k
K8DWellfield Technologies Inc	0.0142 € (47.92%)	500
A07Avance Gas Holding Ltd	0.27 € (-46.80%)	1.26M
3SHShunfeng International Clean Energy Limited	0.0014 € (-36.36%)	3k
SQRSaia Inc.	216.00 € (-30.77%)	528
L7C2Windfall Geotek Inc	0.008 € (-30.43%)	32.29k
3PJ1Golden Dory Resourses	0.02 € (-25.93%)	40k
DMLSayona Mining Limited	0.0113 € (4.63%)	2.52M
11LCanopy Growth Corporation	1.222 € (-6.86%)	2.31M
PF8European Lithium Limited	0.0314 € (3.29%)	2.18M
D7GNel ASA	0.1982 € (-1.49%)	2.15M
3CPXiaomi Corporation	5.459 € (-1.83%)	1.56M

northam43

northam43 6 minutes ago

SPX Daily Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/25/ajulc1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/25/gzkteDaily_Chart.png

PatB1

PatB1 6 minutes ago

That would give me a chance to get out of this train wreck!

Bourbon_on_my_cornflakes

Bourbon_on_my_cornflakes 7 minutes ago

Questions for AGM
1. What is status of EMA filing, how fast will any questions be answered by AVXL
2. Will FDA filing proceed after EMA questions answered.
3. Any serious partnership discussions? Parameter of a deal AVXL is seeking?
4. PD trial?
5. Rett filing?.

SkyLimit2022

SkyLimit2022 7 minutes ago

Gro,

Yes, NWBO’s platforms are INCREDIBLE, and additional clinical data are being collected today and will continue to be gathered moving forward…

https://investorshub.advfn.com/uimage/uploads/2025/4/25/tfmyjgiphy.gif

BP is starting to recognize the “incr

MightyX

MightyX 7 minutes ago

Looking AH setting up Monday new-52wk high close

TenKay

TenKay 7 minutes ago

And yet…price goes nowhere, more sells than buys, mediocre volume, and very very few of those bids seem to want to cross the fence by even one tick and slap dat ask.

LOL.

It’s flippers looking for a few tick flip…not anyone that will hold very long at all.

MITIman007

MITIman007 7 minutes ago

After 2022, that was my sell signal.

northam43

northam43 7 minutes ago

SPX Daily Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/25/ajulc1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/25/gzkteDaily_Chart.png

vlispxpert

vlispxpert 7 minutes ago

Well, keep eye out for "zone" picks, they're almost guaranteed winners...I'm even amazed at how they bounce almost every time they hit the "zone" ;)

Aquahoya

Aquahoya 7 minutes ago

They just give shares to the lender. This will happen a lot until they cool off.

Galzus Research

Galzus Research 8 minutes ago

It's really hard to say. But a control group will be required if it's going to be like any of the other confirmatory trials.

Granted, some of those randomized confirmatory trials have been moving things into a different disease setting. Like tucatinib-trastuzumab in HER2-positive CRC

mrkirby

mrkirby 9 minutes ago

You can't argue with results.

81vette

81vette 10 minutes ago

You nailed BULL to the wall bro! Excellent calls

LandPro

LandPro 10 minutes ago

Yes, pay attention folks to what this Ashold is lying about. We all know what his agenda is. Lying and telling fairy tale is his MO.

capgain

capgain 10 minutes ago

Otis Taylor - Hey Joe - Must see photos.

https://www.youtube.com/watch?v=woaX1ImmpDE

StayHumble

StayHumble 10 minutes ago

💹wow Xpert $GNCP BUYS+ info wow ✅💹✅💹 https://gncc-capital.com/Properties.html

gimmegimmeminemine

gimmegimmeminemine 10 minutes ago

They gotta be pretty damn close by now
Hopes and dreams
Maybe
Maybe not
Who knows?
I dont think so.
Not this batch or in a few weeks.
Hell, do we even know if he will PR it ?
Why would he? I mean it would be the starting point of the first

Galzus Research

Galzus Research 11 minutes ago

What's the point of responding if you don't have anything to add?

bigfart

bigfart 11 minutes ago

That was then now is a different catalyst

hedge_fun

hedge_fun 11 minutes ago

Any word on the “updated permitting” they’re……

waiting on?

madras50

madras50 11 minutes ago

anyone know what the short position on this is? Possible for a major squeeze?

Bourbon_on_my_cornflakes

Bourbon_on_my_cornflakes 12 minutes ago

Mike, up 4.79%, short interest declined

not a schitty week for a change

Invesco Capital Management

Genworth Mortgage Insura...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions